FDA — authorised 20 August 2014
- Application: NDA205625
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: supplemented
FDA authorised Arnuity on 20 August 2014
Yes. FDA authorised it on 20 August 2014; FDA has authorised it.
GLAXOSMITHKLINE holds the US marketing authorisation.